TVM is a leading international venture capital firm focused on invest¬ing in life science innovations. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC), that leverages the firm’s strate¬gic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
FYB Company Profile